Intraoperative ultrasound is an effective and preferable technique to localize non-palpable breast tumors
Introduction
Breast cancer screening has dramatically increased the diagnosis of suspicious, non-palpable lesions of the breast.1
Screening mammography can reduce mortality by 20% in women with breast cancer,2 and early diagnosis of small, non-palpable tumors is associated with both a lower stage of disease and a decreased incidence of lymph node involvement, compared with the palpable counterpart. This maximises breast conservation, allows minimally invasive surgery on the sentinel lymph node, and enhances acceptability and quality of life of patients with this disease.3
To date, wire localization (WL), either under ultrasound or stereotaxic guidance, has been the most common technique used for preoperative localization of these tumors. However, WL has some disadvantages such as pain and discomfort in some patients, and occasionally carries risks of complications including dislodgement of the wire, intraoperative wire transaction, retention of wire fragments, thermal injury with the use of cautery, hematoma and even syncope. The procedure is performed in most institutions as an additional step outside the operating room, with further organization and scheduling problems.
Therefore, a procedure with the same accuracy, a higher rate of free margins and less discomfort for the patient would seem preferable.
Intraoperative ultrasound localization (IOUS) of non-palpable breast lesions has been first described more than 10 years ago, and preliminary reports have been favourable.4, 5, 6
We report, herein, a prospective study and describe our experience with IOUS.
Section snippets
Patients
Consecutive patients with both benign or malignant non-palpable breast lesions, who underwent IUL, were prospectively studied in our Institution from May 2006 to June 2007.
All patients who had sonographically visible lesions, not necessarily noted by mammography, were included.
Patients with benign lesions were considered for surgery because they had growing breast lesions, because results of fine-needle aspiration biopsy were inconclusive, or because of patients' preference.
Intraoperative ultrasound technique
Esaote Technos MPX
Patients' characteristics
Seventy-seven patients were operated during the period of the study. The median age of the patients was 54 years (36–87), while the median diameter of the lesions was 9 mm (4–17). There were 60 malignant and 17 benign lesions (Table 1). Among the former group, there were 54 invasive ductal, 4 invasive lobular, and 2 pure ductal in situ (DCIS) cancers. All these patients underwent sentinel lymph node biopsy after intradermal injection of 0.6 mCi of Tc-99 filtered nanocolloid (Nanocoll – Nycomed
Discussion
In our experience, IOUS was an excellent tool to identify non-palpable breast lesions, to remove them with satisfactorily margins in almost all cases, while the re-excision rate was only 3%. This is a key factor to minimize both an undesirable return to the operating room and an associated decrease in the cosmetic result in the case of breast conservation.7 Furthermore, patients with breast cancer removed with clear margins at the first excision seem to have a decreased risk of local recurrence
Conflict of interest
There are no conflicts of interest to be reported by all authors of this manuscript. All authors contributed significantly to this paper.
Acknowledgements
This study was supported by a grant from the Prometeus Foundation, ONLUS, for the development of training and cancer research.
References (31)
- et al.
A single institution review of new breast malignancies identified solely by sonography
J Am Coll Surg
(2006) - et al.
Clinically and mammographically occult breast lesions: detection and classification with high resolution sonography
Semin Ultrasound CT MR
(2000) - et al.
Wire localized biopsy of breast lesions: a review of 425 cases found in screening or clinical mammography
Clin Radiol
(1993) - et al.
Lumpectomy margins, reexcision, and local recurrence of breast cancer
Am J Surg
(2000) - et al.
Intraoperative ultrasound-guided breast biopsy
Am J Surg
(2000 Dec) - et al.
Intraoperative ultrasound localization to guide surgical excision of nonpalpable breast carcinoma
J Am Coll Surg
(1999) - et al.
Intraoperative ultrasonography guidance is accurate and efficient according to results in 100 breast cancer patients
Am J Surg
(2003) - et al.
Radioguided occult breast lesion location (ROLL)
Rev Esp Med Nucl
(2005) - et al.
Mammographic screening: a key factor in the control of breast cancer
Cancer J
(2003) - et al.
Screening for breast cancer with mammography
Cochrane Database Syst Rev
(Oct 18, 2006)
Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management
Am Surg
Ultrasonography: an alternative to x-ray-guided needle localization of nonpalpable breast masses
Surgery
Localization of impalpable breast masses: value of sonography in the operating room and scanning of excised specimens
Am J Roentgenol
Nonpalpable lesions of the breast. A new technique of ultrasound-guided excision biopsy
Minerva Chir
Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma
J Clin Oncol
Cited by (42)
Surgeon-led Intraoperative Ultrasound Localization for Nonpalpable Breast Cancers: Results of 5 Years of Practice
2019, Clinical Breast CancerCitation Excerpt :The basis of the ultrasound technique for skin marking is identical across all the studies. Some studies use ultrasound after the specimen has been removed to try and assess the margins intraoperatively to reduce the need for reoperation.24,28,31,33,35,36 The average re-excision rates in this subset were 9%.
Value of intra-operative ultrasound in localization of palpable or non-palpable breast tumors during breast conserving surgery
2018, Egyptian Journal of Radiology and Nuclear MedicineSurgeon performed continuous intraoperative ultrasound guidance decreases re-excisions and mastectomy rates in breast cancer
2017, BreastCitation Excerpt :Non-palpable breast cancers are becoming increasingly more evident owing to the rise in their numbers due to early detection, which accounted for 57.2% in the presented data. Previous studies confirmed the value of US guided excision for nonpalpable breast cancer with a reported re-excision rate between 3% and 9% [12,14,19–22]. Nevertheless, current literature also verifies IOUS′ role in palpable breast cancer.
Low re-excision rate for positive margins in patients treated with ultrasound-guided breast-conserving surgery
2013, BreastCitation Excerpt :In 2002, in a randomized clinical trial involving 49 patients with non-palpable breast cancer, Rahusen et al. demonstrated that intraoperative US localization appears to be somewhat superior to wire localization with regard to margin clearance and has the advantage of preventing the discomfort associated with the wire localization procedure.24 Several previous studies also demonstrated that US-guided surgical excision for non-palpable breast cancers is an effective and preferable technique, with a re-excision rate between 3% and 9%.6,15,16,25,26 Even with palpable breast cancers, US-guided excision decreased the re-excision lumpectomy rate.12
Ultrasound-guided excision combined with intraoperative assessment of gross macroscopic margins decreases the rate of reoperations for non-palpable invasive breast cancer
2013, BreastCitation Excerpt :The ideal technique for the removal of non-palpable invasive cancers of the breast should be performed in a single intervention and should be simple, accurate, and cost-effective, and it should provide a good cosmetic result and be comfortable for the patient. In our experience, intraoperative ultrasound is an excellent method for the localization and excision of non-palpable breast invasive cancers, with an efficiency close to 100%, comparable to other recently published studies.3,5,9–11,13 In our cases, a preoperative diagnosis was made with core needle biopsy, which in some cases allowed us to place a marker at the biopsy site, which provided us with the location of the lesion by means of ultrasound.